← Leaderboards
Catarina E Hioe
James J Peters Va Medical Center
$16,289,289
Attributed
$18,374,526
Total exposure
16
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,374,526 · 11
VA$0 · 5
By mechanism
R01$14,562,375 · 5
R21$1,920,223 · 4
P01$1,244,620 · 1
R56$647,308 · 1
I01$0 · 4
IK6$0 · 1
Top collaborators
- Ann Jones Hessell4 shared
- Chitra Upadhyay2 shared
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingVaccinesVirusDesignHiv InfectionsCellsInfectionEpitopesAntibodiesResponseAntigensHiv Envelope Protein Gp120Hiv-1Hiv VaccineReportingVaccinationProteinsSiteImmunePreventGlycoproteinsPandemic DiseaseMonoclonal AntibodiesVirus Envelope
Grant awards (67)
Using immune complex vaccines to optimize antibody responses to HIV Env$845,474
R01 · FY2025 · AI · contact PI
Vaccine targeting HIV sites of vulnerability$0
I01 · FY2025 · VA · contact PI
COVID-19: Significance of Fc properties and functions in antibody responses against SARS-CoV-2$0
I01 · FY2025 · VA · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2025 · VA · contact PI
Using immune complex vaccines to optimize antibody responses to HIV Env$845,905
R01 · FY2024 · AI · contact PI
Vaccine targeting HIV sites of vulnerability$0
I01 · FY2024 · VA · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2024 · VA · contact PI
COVID-19: Significance of Fc properties and functions in antibody responses against SARS-CoV-2$0
I01 · FY2024 · VA · contact PI
Using immune complex vaccines to optimize antibody responses to HIV Env$1,131,742
R01 · FY2023 · AI · contact PI
BLR&D Research Career Scientist Award$0
IK6 · FY2023 · VA · contact PI
COVID-19: Significance of Fc properties and functions in antibody responses against SARS-CoV-2$0
I01 · FY2023 · VA · contact PI
Vaccine targeting HIV sites of vulnerability$0
I01 · FY2023 · VA · contact PI
Harnessing Abs specific for immunogenic and conserved Env epitopes to protect against HIV$813,378
R01 · FY2022 · AI · contact PI
BLR&D Research Career Scientist Award$0
IK6 · FY2022 · VA · contact PI
COVID-19: Significance of Fc properties and functions in antibody responses against SARS-CoV-2$0
I01 · FY2022 · VA · contact PI
Vaccine targeting HIV sites of vulnerability$0
I01 · FY2022 · VA · contact PI
Using immune complex vaccines to optimize antibody responses to HIV Env$834,710
R01 · FY2021 · AI · contact PI
Harnessing Abs specific for immunogenic and conserved Env epitopes to protect against HIV$813,378
R01 · FY2021 · AI · contact PI
Biologic consequences of HIV-1 interaction with bacteria$257,038
R21 · FY2021 · AI · contact PI
BLR&D Research Career Scientist Award$0
IK6 · FY2021 · VA · contact PI
Understanding Th-monocyte interactions in HIV infection$0
I01 · FY2021 · VA · contact PI
Using immune complex vaccines to optimize antibody responses to HIV Env$875,894
R01 · FY2020 · AI · contact PI
Harnessing Abs specific for immunogenic and conserved Env epitopes to protect against HIV$813,378
R01 · FY2020 · AI · contact PI
Biologic consequences of HIV-1 interaction with bacteria$243,838
R21 · FY2020 · AI · contact PI
BLR&D Research Career Scientist Award$0
IK6 · FY2020 · VA · contact PI
Understanding Th-monocyte interactions in HIV infection$0
I01 · FY2020 · VA · contact PI
Harnessing Abs specific for immunogenic and conserved Env epitopes to protect against HIV$808,293
R01 · FY2019 · AI · contact PI
Understanding Th-monocyte interactions in HIV infection$0
I01 · FY2019 · VA · contact PI
BLR&D Research Career Scientist Award$0
IK6 · FY2019 · VA · contact PI
Harnessing Abs specific for immunogenic and conserved Env epitopes to protect against HIV$843,043
R01 · FY2018 · AI · contact PI
Role of signal sequence variation in governing HIV Env Functions$219,538
R21 · FY2018 · AI
Understanding Th-monocyte interactions in HIV infection$0
I01 · FY2018 · VA · contact PI
Role of signal sequence variation in governing HIV Env Functions$262,685
R21 · FY2017 · AI
Administrative Core$216,138
P01 · FY2017 · AI · contact PI
Contributions of anti-V2 antibodies in protection against HIV$588,002
R01 · FY2016 · AI · contact PI
Administrative Core$216,923
P01 · FY2016 · AI · contact PI
Modulating Ab response to HIV Env gp120 by monoclonal antibody - Resubmission- 1$172,031
R21 · FY2016 · AI · contact PI
Contributions of anti-V2 antibodies in protection against HIV$333,283
R01 · FY2015 · AI · contact PI
Contributions of anti-V2 antibodies in protection against HIV$257,904
R01 · FY2015 · AI · contact PI
Modulating Ab response to HIV Env gp120 by monoclonal antibody - Resubmission - 1$254,250
R21 · FY2015 · AI · contact PI
Administrative Core$238,210
P01 · FY2015 · AI · contact PI
Virological Synapse and Signaling for Efficient HIV Transmission$0
I01 · FY2015 · VA · contact PI
Administrative Core$256,089
P01 · FY2014 · AI · contact PI
HIV Envelope gp120-induced immunosuppression$224,808
R56 · FY2014 · AI · contact PI
Virological Synapse and Signaling for Efficient HIV Transmission$0
I01 · FY2014 · VA · contact PI
Contributions of anti-V2 antibodies in protection against HIV$524,558
R01 · FY2013 · AI · contact PI
Contributions of anti-V2 antibodies in protection against HIV$295,971
R01 · FY2013 · AI · contact PI
Administrative Core$144,163
P01 · FY2013 · AI · contact PI
Virological Synapse and Signaling for Efficient HIV Transmission$0
I01 · FY2013 · VA · contact PI
Contributions of anti-V2 antibodies in protection against HIV$527,939
R01 · FY2012 · AI · contact PI
Administrative Core$173,097
P01 · FY2012 · AI · contact PI
Virological Synapse and Signaling for Efficient HIV Transmission$0
I01 · FY2012 · VA · contact PI
HIV Envelope gp120-induced immunosuppression$422,500
R56 · FY2011 · AI · contact PI
CC Chemokine Secretion to Protect Antigen-Specific CD4 T Cells from HIV$422,500
R01 · FY2010 · AI · contact PI
HIV Vaccines that Elicit Immune Responses to Virus Env$318,742
R01 · FY2010 · AI · contact PI
CC Chemokine Secretion to Protect Antigen-Specific CD4 T Cells from HIV$422,604
R01 · FY2009 · AI · contact PI
HIV Vaccines that Elicit Immune Responses to Virus Env$321,962
R01 · FY2009 · AI · contact PI
HIV Env-Induced Synapse and Signaling$49,852
R21 · FY2009 · AI · contact PI
HIV Vaccines that Elicit Immune Responses to Virus Env$321,962
R01 · FY2008 · AI · contact PI
HIV Env-Induced Synapse and Signaling$207,491
R21 · FY2008 · AI · contact PI
HIV Vaccines that Elicit Immune Responses to Virus Env$328,198
R01 · FY2007 · AI · contact PI
HIV Env-Induced Synapse and Signaling$253,500
R21 · FY2007 · AI · contact PI
HIV Vaccines that Elicit Immune Responses to Virus Env$363,000
R01 · FY2006 · AI · contact PI
Why Th Cells from HIV+ Don't Respond to HIV Antigens$253,500
R01 · FY2005 · AI
Why Th Cells from HIV+ Don't Respond to HIV Antigens$253,500
R01 · FY2004 · AI
Why Th Cells from HIV+ Don't Respond to HIV Antigens$253,125
R01 · FY2003 · AI
Why Th Cells from HIV+ Don't Respond to HIV Antigens$150,430
R01 · FY2002 · AI